Cleveland BioLabs
CBLI
#10167
Rank
โ‚น4.67 B
Marketcap
โ‚น301.78
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: โ‚น4.67 Billion

As of July 2026 Cleveland BioLabs has a market cap of โ‚น4.67 Billion. This makes Cleveland BioLabs the world's 10167th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚น4.06 B11.18%
2021โ‚น3.65 B11.21%
2020โ‚น3.28 B577.12%
2019โ‚น0.48 B-39.21%
2018โ‚น0.79 B-72.37%
2017โ‚น2.88 B172.4%
2016โ‚น1.06 B-58.39%
2015โ‚น2.54 B146.8%
2014โ‚น1.03 B-68.38%
2013โ‚น3.26 B0.26%
2012โ‚น3.25 B-39.37%
2011โ‚น5.37 B-42.66%
2010โ‚น9.36 B201.94%
2009โ‚น3.10 B121.3%
2008โ‚น1.40 B-68.53%
2007โ‚น4.45 B68.75%
2006โ‚น2.63 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚น29.045 T 621,696.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น103.053 T 2,206,004.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น19.223 T 411,433.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น9.835 T 210,454.39%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น11.300 T 241,820.03%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.231 T 218,922.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚น0.54 B-88.31%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น109.26 B 2,239.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น1.99 B-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA